11677

    532612

    INDOCO

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    INDOCO REMEDIES LTD. Share Price Today

    INDOCO REMEDIES LTD. is currently trading at ₹221.41, down by ₹0.31 from the previous close. The stock touched an intraday high of ₹223.00 and a low of ₹217.43 during the latest trading session. Over the past one year, INDOCO REMEDIES LTD. has delivered a loss of 21.93%, while the stock has declined 7.85% in the last one month.

    INDOCO REMEDIES LTD. performance

    Today’s low Today’s high
    ₹ 217.43 ₹ 223.00
    ₹ 221.41
    52 week low 52 week high
    ₹ 162.19 ₹ 332.20
    ₹ 221.41
    Open Price ₹ 223.00
    Prev. Close ₹ 221.73
    Volume (Shares) 88660.00
    Total traded value ₹ 196.30
    Upper Circuit ₹ 266.07
    Lower Circuit ₹ 177.39
    info

    Investment Returns

    Over 1 Month -7.85% Over 3 Months -11.53% Over 6 Months 8.15% Over 1 Year -21.93%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    INDOCO REMEDIES LTD. fundamentals


    • Market cap (Cr) 2,043.70
    • P/E Ratio (TTM) 19.52
    • Beta 0.91
    • Book Value / share 119.08
    • Return on equity -0.89%
    • EPS (TTM) 2.33
    • Dividend yield 0.09%
    • Net profit/quarter (Cr) 82.32
    info icon alternate text
    • Market cap (Cr) 2,038.50
    • P/E Ratio (TTM) 19.52
    • Beta 0.71
    • Book Value / share 119.08
    • Return on equity -0.89%
    • EPS (TTM) 2.33
    • Dividend yield 0.09%
    • Net profit/quarter (Cr) 82.32
    info icon alternate text

    INDOCO REMEDIES LTD. Financials

    Open financial information
    Revenue
    Net income
    Particulars JUN 2026 (Values in Cr)
    Revenue 408.12
    Operating Expense 417.56
    Net Profit 82.32
    Net Profit Margin (%) 20.17
    Earnings Per Share (EPS) 8.92
    EBITDA 144.02
    Effective Tax Rate (%) 11.69
    Particulars MAR 2026 (Values in Cr)
    Revenue 429.06
    Operating Expense 435.54
    Net Profit 27.35
    Net Profit Margin (%) 6.37
    Earnings Per Share (EPS) 2.96
    EBITDA 77.06
    Effective Tax Rate (%) 0.97
    Particulars DEC 2025 (Values in Cr)
    Revenue 389.57
    Operating Expense 422.12
    Net Profit -20.00
    Net Profit Margin (%) -5.13
    Earnings Per Share (EPS) -2.17
    EBITDA 27.06
    Effective Tax Rate (%) 2.20
    Particulars SEP 2025 (Values in Cr)
    Revenue 429.30
    Operating Expense 438.37
    Net Profit 15.05
    Net Profit Margin (%) 3.50
    Earnings Per Share (EPS) 1.63
    EBITDA 59.40
    Effective Tax Rate (%) -54.20
    Particulars JUN 2025 (Values in Cr)
    Revenue 385.61
    Operating Expense 428.30
    Net Profit -28.07
    Net Profit Margin (%) -7.27
    Earnings Per Share (EPS) -3.04
    EBITDA 20.40
    Effective Tax Rate (%) 1.19
    Particulars MAR 2026 (Values in Cr)
    Revenue 1633.54
    Operating Expense 1724.32
    Net Profit -5.66
    Net Profit Margin (%) -0.34
    Earnings Per Share (EPS) -0.61
    EBITDA 183.93
    Effective Tax Rate (%) 50.65
    Particulars MAR 2025 (Values in Cr)
    Revenue 1494.78
    Operating Expense 1545.03
    Net Profit -8.73
    Net Profit Margin (%) -0.58
    Earnings Per Share (EPS) -0.95
    EBITDA 147.51
    Effective Tax Rate (%) -18.45
    Particulars MAR 2024 (Values in Cr)
    Revenue 1761.95
    Operating Expense 1657.62
    Net Profit 116.64
    Net Profit Margin (%) 6.61
    Earnings Per Share (EPS) 12.66
    EBITDA 278.02
    Effective Tax Rate (%) 23.87
    Particulars MAR 2023 (Values in Cr)
    Revenue 1638.13
    Operating Expense 1477.43
    Net Profit 141.36
    Net Profit Margin (%) 8.62
    Earnings Per Share (EPS) 15.34
    EBITDA 287.22
    Effective Tax Rate (%) 26.21
    Particulars MAR 2022 (Values in Cr)
    Revenue 1502.70
    Operating Expense 1305.81
    Net Profit 154.52
    Net Profit Margin (%) 10.28
    Earnings Per Share (EPS) 16.77
    EBITDA 329.32
    Effective Tax Rate (%) 34.58
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 110.79
    ROE % -7.31
    ROCE % -0.42
    Total Debt to Total Equity 0.78
    EBITDA Margin 6.35
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 120.40
    ROE % 9.07
    ROCE % 10.76
    Total Debt to Total Equity 0.47
    EBITDA Margin 14.62
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 111.58
    ROE % 14.72
    ROCE % 16.74
    Total Debt to Total Equity 0.30
    EBITDA Margin 17.29
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 98.17
    ROE % 18.50
    ROCE % 22.08
    Total Debt to Total Equity 0.31
    EBITDA Margin 21.40
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 83.45
    ROE % 12.85
    ROCE % 15.06
    Total Debt to Total Equity 0.36
    EBITDA Margin 18.31
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 119.61
    ROE % -0.89
    ROCE % 2.68
    Total Debt to Total Equity 0.57
    EBITDA Margin 9.64
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 122.22
    ROE % 10.83
    ROCE % 12.31
    Total Debt to Total Equity 0.39
    EBITDA Margin 15.52
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 111.45
    ROE % 14.64
    ROCE % 16.66
    Total Debt to Total Equity 0.31
    EBITDA Margin 17.23
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 98.13
    ROE % 18.47
    ROCE % 22.07
    Total Debt to Total Equity 0.31
    EBITDA Margin 21.39
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 83.44
    ROE % 12.75
    ROCE % 15.00
    Total Debt to Total Equity 0.36
    EBITDA Margin 18.28
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 17.06
    Total Assets 2429.91
    Total Liabilities 2429.91
    Total Equity 1018.37
    Share Outstanding 9
    Price to Book Ratio 1.95
    Return on Assets (%) -3.03
    Return on Capital (%) -3.69
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 24.32
    Total Assets 2144.72
    Total Liabilities 2144.72
    Total Equity 1110.49
    Share Outstanding 9
    Price to Book Ratio 2.69
    Return on Assets (%) 4.59
    Return on Capital (%) 5.58
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 13.33
    Total Assets 1658.19
    Total Liabilities 1658.19
    Total Equity 1028.25
    Share Outstanding 9
    Price to Book Ratio 2.92
    Return on Assets (%) 8.57
    Return on Capital (%) 10.59
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 19.77
    Total Assets 1486.09
    Total Liabilities 1486.09
    Total Equity 904.64
    Share Outstanding 9
    Price to Book Ratio 3.84
    Return on Assets (%) 10.41
    Return on Capital (%) 13.47
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 14.33
    Total Assets 1315.06
    Total Liabilities 1315.06
    Total Equity 768.99
    Share Outstanding 9
    Price to Book Ratio 3.46
    Return on Assets (%) 7.07
    Return on Capital (%) 9.05
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 12.03
    Total Assets 2201.16
    Total Liabilities 2201.16
    Total Equity 1103.35
    Share Outstanding 9
    Price to Book Ratio 1.95
    Return on Assets (%) -0.39
    Return on Capital (%) -0.47
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 16.93
    Total Assets 1960.60
    Total Liabilities 1960.60
    Total Equity 1126.61
    Share Outstanding 9
    Price to Book Ratio 2.69
    Return on Assets (%) 5.94
    Return on Capital (%) 7.18
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 12.39
    Total Assets 1659.67
    Total Liabilities 1659.67
    Total Equity 1027.02
    Share Outstanding 9
    Price to Book Ratio 2.92
    Return on Assets (%) 8.51
    Return on Capital (%) 10.54
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 19.20
    Total Assets 1487.56
    Total Liabilities 1487.56
    Total Equity 904.30
    Share Outstanding 9
    Price to Book Ratio 3.84
    Return on Assets (%) 10.38
    Return on Capital (%) 13.45
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 14.05
    Total Assets 1316.56
    Total Liabilities 1316.56
    Total Equity 768.92
    Share Outstanding 9
    Price to Book Ratio 3.46
    Return on Assets (%) 7.01
    Return on Capital (%) 9.41
    Particulars MAR 2025 (Values in Cr)
    Net Income -75.36
    Cash from Operations 111.05
    Cash from Investing -339.11
    Cash from Financing 241.42
    Net change in Cash -2.75
    Free Cash Flow 467.20
    Particulars MAR 2024 (Values in Cr)
    Net Income 124.27
    Cash from Operations 174.65
    Cash from Investing -433.82
    Cash from Financing 280.43
    Net change in Cash 3.30
    Free Cash Flow 601.95
    Particulars MAR 2023 (Values in Cr)
    Net Income 192.79
    Cash from Operations 240.48
    Cash from Investing -208.17
    Cash from Financing 22.80
    Net change in Cash -6.54
    Free Cash Flow 447.73
    Particulars MAR 2022 (Values in Cr)
    Net Income 236.57
    Cash from Operations 214.90
    Cash from Investing -121.40
    Cash from Financing -44.37
    Net change in Cash 8.04
    Free Cash Flow 340.23
    Particulars MAR 2021 (Values in Cr)
    Net Income 131.99
    Cash from Operations 101.94
    Cash from Investing -66.69
    Cash from Financing -29.87
    Net change in Cash -14.34
    Free Cash Flow 178.78
    Particulars MAR 2025 (Values in Cr)
    Net Income -8.37
    Cash from Operations 106.36
    Cash from Investing -259.79
    Cash from Financing 168.62
    Net change in Cash -0.40
    Free Cash Flow 364.79
    Particulars MAR 2024 (Values in Cr)
    Net Income 141.69
    Cash from Operations 194.36
    Cash from Investing -301.70
    Cash from Financing 122.40
    Net change in Cash -2.51
    Free Cash Flow 373.39
    Particulars MAR 2023 (Values in Cr)
    Net Income 191.59
    Cash from Operations 240.17
    Cash from Investing -208.51
    Cash from Financing 22.80
    Net change in Cash -6.91
    Free Cash Flow 429.56
    Particulars MAR 2022 (Values in Cr)
    Net Income 236.23
    Cash from Operations 214.53
    Cash from Investing -121.41
    Cash from Financing -44.36
    Net change in Cash 7.77
    Free Cash Flow 339.86
    Particulars MAR 2021 (Values in Cr)
    Net Income 131.35
    Cash from Operations 101.92
    Cash from Investing -66.69
    Cash from Financing -29.82
    Net change in Cash -14.35
    Free Cash Flow 178.77
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 46.63 19.35 2.25 357.34 23.12 47.39
    BLISS GVS PHARMA LTD. 477.10 38.41 4.24 5068.90 118.35 552.90
    CIPLA LTD. 1472.00 33.23 3.45 118914.83 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 559.55 26.17 4.05 1646.81 256.40 568.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 46.63 32.61 6.00 357.34 23.12 47.39
    AMRUTANJAN HEALTH CARE LTD. 522.95 23.44 4.08 1511.88 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8188.15 107.01 23.45 20470.38 7630.00 9850.00
    BLISS GVS PHARMA LTD. 477.10 51.63 4.38 5068.90 118.35 552.90

    INDOCO REMEDIES LTD. shareholding pattern

    Holding
    22.18%
    58.86%
    1.27%
    17.67%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    INDOCO REMEDIES LTD. Technicals Summary

    221.41 -0.14 redarrow
    red-green-graph indicator
    15 Bearish
    1 Bullish
    • 5 Days 222.60
    • 26 Days 231.70
    • 10 Days 225.70
    • 50 Days 230.30
    • 12 Days 227.10
    • 100 Days 227.10
    • 20 Days 230.60
    • 200 Days 233.90
    222.39 PIVOT
    First Support 220.38 First Resistance 223.74 Second Support 219.03 Second Resistance 225.75 Third Support 217.02 Third Resistance 227.10
    RSI 41.13 ADX 21.05 MACD -4.60 Williams % R -89.03 Commodity Channel Index (CCI) -86.05
    Date 2026-08-07 Week 35774.00 Same Day 13475.00 Month 71493.00
    1 Year 0.91 3 Year 0.85
    Over 1 Month
    -7.85% down
    Over 1 Year
    -21.93% down
    Over 3 Months
    -11.53% down
    Over 3 Years
    -11.67% down
    Over 6 Months
    8.15% down
    Over 5 Years
    -13.25% down

    INDOCO REMEDIES LTD. Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    04 Sep 2025 0.2 Final 04 Sep 2025 Equity shares
    19 Sep 2024 1.5 Final 19 Sep 2024 Equity shares
    18 Sep 2023 2.25 Final 19 Sep 2023 Equity shares
    14 Sep 2022 0.75 Special 16 Sep 2022 Equity shares
    14 Sep 2022 1.5 Final 15 Sep 2022 Equity shares
    17 Sep 2021 1.5 Final 21 Sep 2021 Equity shares
    18 Sep 2020 0.3 Final 22 Sep 2020 Equity shares
    22 Aug 2019 0.3 Final 26 Aug 2019 Equity shares
    31 Aug 2018 1.0 Final 04 Sep 2018 Equity shares
    31 Jul 2017 1.6 Final 02 Aug 2017 Equity shares
    20 Jul 2016 0.2 Final 22 Jul 2016 Equity shares
    17 Mar 2016 1.4 Interim 18 Mar 2016 Equity shares
    21 Jul 2015 1.6 Final 23 Jul 2015 Equity shares
    21 Jul 2014 1.4 Final 23 Jul 2014 Equity shares
    19 Jul 2013 1.1 Final 23 Jul 2013 Equity shares
    20 Jul 2012 1.1 Final 24 Jul 2012 Equity shares
    19 Jul 2011 8.0 Final 21 Jul 2011 Equity shares
    13 Jul 2010 7.0 Final 15 Jul 2010 Equity shares
    09 Sep 2009 2.0 Final 11 Sep 2009 Equity shares
    11 Dec 2008 3.25 Interim 12 Dec 2008 Equity shares
    19 Sep 2008 5.0 Final 23 Sep 2008 Equity shares
    13 Dec 2007 6.5 Final 15 Dec 2007 Equity shares
    15 Sep 2005 0.0 Final 17 Sep 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    17 May 2012 17 May 2012 1:2
    Ex-Date Old FV NEW FV Record Date
    17 May 2012 10.0 2.0 19 May 2012
    Dividend date Dividend amount Dividend type Record date Instrument type
    04 Sep 2025 0.2 Final 04 Sep 2025 Equity shares
    19 Sep 2024 1.5 Final 19 Sep 2024 Equity shares
    18 Sep 2023 2.25 Final 19 Sep 2023 Equity shares
    14 Sep 2022 0.75 Special 16 Sep 2022 Equity shares
    14 Sep 2022 1.5 Final 15 Sep 2022 Equity shares
    17 Sep 2021 1.5 Final 21 Sep 2021 Equity shares
    18 Sep 2020 0.3 Final 22 Sep 2020 Equity shares
    22 Aug 2019 0.3 Final 26 Aug 2019 Equity shares
    31 Aug 2018 1.0 Final 04 Sep 2018 Equity shares
    31 Jul 2017 1.6 Final 02 Aug 2017 Equity shares
    20 Jul 2016 0.2 Final 22 Jul 2016 Equity shares
    17 Mar 2016 1.4 Interim 18 Mar 2016 Equity shares
    21 Jul 2015 1.6 Final 23 Jul 2015 Equity shares
    21 Jul 2014 1.4 Final 23 Jul 2014 Equity shares
    19 Jul 2013 1.1 Final 23 Jul 2013 Equity shares
    20 Jul 2012 1.1 Final 24 Jul 2012 Equity shares
    19 Jul 2011 8.0 Final 21 Jul 2011 Equity shares
    13 Jul 2010 7.0 Final 15 Jul 2010 Equity shares
    09 Sep 2009 2.0 Final 11 Sep 2009 Equity shares
    11 Dec 2008 3.25 Interim 12 Dec 2008 Equity shares
    19 Sep 2008 5.0 Final 23 Sep 2008 Equity shares
    13 Dec 2007 6.5 Final 15 Dec 2007 Equity shares
    15 Sep 2005 0.0 Final 17 Sep 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    17 May 2012 17 May 2012 1:2
    Ex-Date Old FV NEW FV Record Date
    17 May 2012 10.0 2.0 19 May 2012

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Indoco Remedies Ltd?

    Answer Field

    Indoco Remedies Ltd share price is for NSE ₹ 221.41 & for BSE ₹ 221.50 as on Aug 10 2026 03:30 PM.

    What is the Market Cap of Indoco Remedies Ltd Share?

    Answer Field

    The market cap of Indoco Remedies Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Aug 10 2026 03:30 PM.

    What is the 52 Week High and Low of Indoco Remedies Ltd?

    Answer Field

    The 52 Week High and Low of Indoco Remedies Ltd for NSE is ₹ 332.20 and ₹ 162.19 and for BSE is ₹ 332.15 and ₹ 163.70.

    What is 1 year return for Indoco Remedies Ltd?

    Answer Field

    The 1 year returns on the stock has been -21.93%.

    What is the P/E Ratio of Indoco Remedies Ltd Share?

    Answer Field

    As on Aug 10 2026 03:30 PM the price-to-earnings (PE) ratio for Indoco Remedies Ltd share is 19.52.

    What is the PB ratio of Indoco Remedies Ltd Share?

    Answer Field

    As on Aug 10 2026 03:30 PM, the price-to-book (PB) ratio for Indoco Remedies Ltd share is 119.08.

    How to Buy Indoco Remedies Ltd Share?

    Answer Field

    You can trade in Indoco Remedies Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Indoco Remedies Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Indoco Remedies Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Indoco Remedies Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |